Literature DB >> 17124755

WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17124755

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  71 in total

1.  Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.

Authors:  Julia Hutter; Marcela F Pasetti; Doh Sanogo; Milagritos D Tapia; Samba O Sow; Myron M Levine
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Haemophilus influenzae type b carriage and novel bacterial population structure among children in urban Kathmandu, Nepal.

Authors:  E J Williams; J Lewis; T John; J C Hoe; L Yu; S Dongol; D F Kelly; D T Griffiths; A Shah; B Limbu; R Pradhan; F Mawas; S Shrestha; S Thorson; A M Werno; D R Murdoch; N Adhikari; A J Pollard
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

3.  Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countries.

Authors:  Adam L Cohen; Terri B Hyde; Jennifer Verani; Margaret Watkins
Journal:  Bull World Health Organ       Date:  2012-04-01       Impact factor: 9.408

4.  Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?

Authors:  Romeo S Rodriguez; Cesar Mascarenas; Carlos J Conde-Glez; Jaime Inostroza; Sonia Villanueva; María Elena Velázquez; Miguel Angel Sánchez-Alemán; Gabriela Echániz
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

Review 5.  DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

6.  A policy framework for accelerating adoption of new vaccines.

Authors:  Orin S Levine; Rana Hajjeh; John Wecker; Thomas Cherian; Katherine L O'Brien; Maria Deloria Knoll; Lois Privor-Dumm; Hans Kvist; Angeline Nanni; Allyson P Bear; Mathuram Santosham
Journal:  Hum Vaccin       Date:  2010-12-01

Review 7.  Haemophilus influenzae type a infection and its prevention.

Authors:  Zhigang Jin; Sandra Romero-Steiner; George M Carlone; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

Review 8.  Vaccination greatly reduces disease, disability, death and inequity worldwide.

Authors:  F E Andre; R Booy; H L Bock; J Clemens; S K Datta; T J John; B W Lee; S Lolekha; H Peltola; T A Ruff; M Santosham; H J Schmitt
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

9.  Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Authors:  Ulla Kou Griffiths; Andrew Clark; Rana Hajjeh
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

10.  Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.

Authors:  Phuc Le; Ulla K Griffiths; Dang Duc Anh; Luisa Franzini; Wenyaw Chan; J Michael Swint
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.